98 related articles for article (PubMed ID: 23323915)
1. Aspirin, PIK3CA mutation, and colorectal-cancer survival.
Sahin IH; Garrett C
N Engl J Med; 2013 Jan; 368(3):289. PubMed ID: 23323915
[No Abstract] [Full Text] [Related]
2. Aspirin, PIK3CA mutation, and colorectal-cancer survival.
Viúdez A; Hernandez I; Vera R
N Engl J Med; 2013 Jan; 368(3):289. PubMed ID: 23323914
[No Abstract] [Full Text] [Related]
3. Aspirin, PIK3CA mutation, and colorectal-cancer survival.
Ogino S; Liao X; Chan AT
N Engl J Med; 2013 Jan; 368(3):289-90. PubMed ID: 23323913
[No Abstract] [Full Text] [Related]
4. Aspirin--from prevention to targeted therapy.
Pasche B
N Engl J Med; 2012 Oct; 367(17):1650-1. PubMed ID: 23094728
[No Abstract] [Full Text] [Related]
5. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.
Liao X; Lochhead P; Nishihara R; Morikawa T; Kuchiba A; Yamauchi M; Imamura Y; Qian ZR; Baba Y; Shima K; Sun R; Nosho K; Meyerhardt JA; Giovannucci E; Fuchs CS; Chan AT; Ogino S
N Engl J Med; 2012 Oct; 367(17):1596-606. PubMed ID: 23094721
[TBL] [Abstract][Full Text] [Related]
6. Potential biomarker for aspirin use in colorectal cancer therapy.
Langley RE; Rothwell PM
Nat Rev Clin Oncol; 2013 Jan; 10(1):8-10. PubMed ID: 23207797
[TBL] [Abstract][Full Text] [Related]
7. Aspirin, the new targeted therapy in colorectal cancer.
Fuchs CS
Clin Adv Hematol Oncol; 2014 Mar; 12(3):186-9. PubMed ID: 24927268
[No Abstract] [Full Text] [Related]
8. Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology.
Ogino S; Lochhead P; Giovannucci E; Meyerhardt JA; Fuchs CS; Chan AT
Oncogene; 2014 Jun; 33(23):2949-55. PubMed ID: 23792451
[TBL] [Abstract][Full Text] [Related]
9. [Aspirin and PIK3CA mutation in colorectal cancer].
Kirstein MM; Vogel A
Z Gastroenterol; 2014 Mar; 52(3):306-7. PubMed ID: 24622874
[No Abstract] [Full Text] [Related]
10. Aspirin therapy for colorectal cancer with PIK3CA mutation: simply complex!
Fuchs CS; Ogino S
J Clin Oncol; 2013 Dec; 31(34):4358-61. PubMed ID: 24166520
[No Abstract] [Full Text] [Related]
11. PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies.
Paleari L; Puntoni M; Clavarezza M; DeCensi M; Cuzick J; DeCensi A
Clin Oncol (R Coll Radiol); 2016 May; 28(5):317-26. PubMed ID: 26712086
[TBL] [Abstract][Full Text] [Related]
12. A small cog in a big wheel: PIK3CA mutations in colorectal cancer.
Stintzing S; Lenz HJ
J Natl Cancer Inst; 2013 Dec; 105(23):1775-6. PubMed ID: 24231451
[No Abstract] [Full Text] [Related]
13. Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation.
Kothari N; Kim R; Jorissen RN; Desai J; Tie J; Wong HL; Faragher I; Jones I; Day FL; Li S; Sakthinandeswaren A; Palmieri M; Lipton L; Schell M; Teer JK; Shibata D; Yeatman T; Sieber OM; Gibbs P; Tran B
Acta Oncol; 2015 Apr; 54(4):487-92. PubMed ID: 25549537
[TBL] [Abstract][Full Text] [Related]
14. PIK3CA mutation is predictive of poor survival in patients with colorectal cancer.
Kato S; Iida S; Higuchi T; Ishikawa T; Takagi Y; Yasuno M; Enomoto M; Uetake H; Sugihara K
Int J Cancer; 2007 Oct; 121(8):1771-8. PubMed ID: 17590872
[TBL] [Abstract][Full Text] [Related]
15. PIK3CA Somatic Mutation Status in Relation to Patient and Tumor Factors in Racial/Ethnic Minorities with Colorectal Cancer.
Phipps AI; Ahnen DJ; Cheng I; Newcomb PA; Win AK; Burnett T
Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1046-51. PubMed ID: 25994739
[TBL] [Abstract][Full Text] [Related]
16. The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis.
Therkildsen C; Bergmann TK; Henrichsen-Schnack T; Ladelund S; Nilbert M
Acta Oncol; 2014 Jul; 53(7):852-64. PubMed ID: 24666267
[TBL] [Abstract][Full Text] [Related]
17. Expression of HLA class I antigen, aspirin use, and survival after a diagnosis of colon cancer.
Reimers MS; Bastiaannet E; Langley RE; van Eijk R; van Vlierberghe RL; Lemmens VE; van Herk-Sukel MP; van Wezel T; Fodde R; Kuppen PJ; Morreau H; van de Velde CJ; Liefers GJ
JAMA Intern Med; 2014 May; 174(5):732-9. PubMed ID: 24687028
[TBL] [Abstract][Full Text] [Related]
18. Aspirin extends life of some patients with colorectal cancer.
Printz C
Cancer; 2013 Feb; 119(3):472-3. PubMed ID: 23341305
[No Abstract] [Full Text] [Related]
19. Beyond KRAS: a new approach in metastatic colorectal cancer.
Winder T; Lenz HJ
Lancet Oncol; 2010 Aug; 11(8):706-7. PubMed ID: 20619738
[No Abstract] [Full Text] [Related]
20. Examining the impact of regular aspirin use and PIK3CA mutations on survival in stage 2 colon cancer.
Murphy C; Turner N; Wong HL; Sinnathamby M; Tie J; Lee B; Desai J; Skinner I; Christie M; Hutchinson R; Lunke S; Waring P; Gibbs P; Tran B
Intern Med J; 2017 Jan; 47(1):88-98. PubMed ID: 27800646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
